tradingkey.logo

Pharmaceuticals & Medical Research

LIST1012
1665.135USD
0.0000.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
4.46TMarket Cap
--Volume
--Open
--High
--Volume
0Up
0Down
792Unchanged
4.46TMarket Cap
1664.742Prev. Close
--Low
--Turnover

Pharmaceuticals & Medical Research

1665.135
0.0000.00%

News

Growth Stocks Near Their Lows: Why Figma, Zoetis, and Pinterest Look Underrated

TradingKey - Currently, if you can invest $5000 into the stock market, it is worth considering as a solid opportunity for this point in time. In addition, a number of Growth Stocks have also been underappreciated due to the audience only focusing on the top-performing companies.

TradingKeyThu, Feb 5
TradingKey - Currently, if you can invest $5000 into the stock market, it is worth considering as a solid opportunity for this point in time. In addition, a number of Growth Stocks have also been underappreciated due to the audience only focusing on the top-performing companies.

Today’s Market Recap: Chip and Software Stocks Crater as AI Conviction Wavers, AMD Plunges 17%

TradingKey - On February 4, 2026, U.S. stocks declined, weighed down by renewed pressure on technology shares. The S&P 500 slipped 0.51% to 6,882, while the Nasdaq Composite fell 1.51% to 22,905, underperforming broader benchmarks as selling concentrated in growth and semiconductor stocks.

TradingKeyThu, Feb 5
TradingKey - On February 4, 2026, U.S. stocks declined, weighed down by renewed pressure on technology shares. The S&P 500 slipped 0.51% to 6,882, while the Nasdaq Composite fell 1.51% to 22,905, underperforming broader benchmarks as selling concentrated in growth and semiconductor stocks.

What to Expect From Eli Lilly in 2026? Is LLY Stock a Good Buy Now?

The company’s main goal and focus in 2026 will be to maintain its leadership position in weight management, whilst expanding further into additional therapeutic areas, so that revenue growth will not be dependent on a singular product. It is expected that Eli Lilly’s stocks will serve as a predictor

TradingKeyWed, Feb 4
The company’s main goal and focus in 2026 will be to maintain its leadership position in weight management, whilst expanding further into additional therapeutic areas, so that revenue growth will not be dependent on a singular product. It is expected that Eli Lilly’s stocks will serve as a predictor

What Are Good Stocks to Invest in Right Now?

TradingKey - Investors like to think that timing the bottom of the stock market is extremely difficult. An expert may get it wrong – as evidenced by many recent mistakes made by professional investors.

TradingKeyWed, Feb 4
TradingKey - Investors like to think that timing the bottom of the stock market is extremely difficult. An expert may get it wrong – as evidenced by many recent mistakes made by professional investors.

Novo Nordisk 2026: Will the Ozempic Makers Benefit From the Strong Demand for Oral Wegovy?

Who owns Ozempic? Novo Nordisk (NVO) does, and that simple fact places the firm at the heart of the global discussion around GLP-1 drugs. But the story today for the market is another one.

TradingKeyWed, Feb 4
Who owns Ozempic? Novo Nordisk (NVO) does, and that simple fact places the firm at the heart of the global discussion around GLP-1 drugs. But the story today for the market is another one.

The Best Stocks to Invest in Right Now for 2026: Better Than Nvidia?

My selection of the best stocks to buy includes MercadoLibre (MELI), Amazon (AMZN), Eli Lilly (LLY), Alphabet (GOOG) (GOOGL), Vertiv (VRT), Nu Holdings (NU) and Walmart (WMT). All these companies each have a unique competitive advantage and possess the financial resilience required to survive market

TradingKeyTue, Jan 27
My selection of the best stocks to buy includes MercadoLibre (MELI), Amazon (AMZN), Eli Lilly (LLY), Alphabet (GOOG) (GOOGL), Vertiv (VRT), Nu Holdings (NU) and Walmart (WMT). All these companies each have a unique competitive advantage and possess the financial resilience required to survive market
KeyAI